ArticlePLoS medicine2021

Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysis.

Jane J Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.